Bank of Montreal’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-6,660
| Closed | -$22K | – | 4499 |
|
|
2018
Q3 | $22K | Sell |
6,660
-19,211
| -74% | -$63.5K | ﹤0.01% | 3365 |
|
|
2018
Q2 | $98K | Sell |
25,871
-95,229
| -79% | -$361K | ﹤0.01% | 2827 |
|
|
2018
Q1 | $495K | Buy |
121,100
+90,000
| +289% | +$368K | ﹤0.01% | 2061 |
|
|
2017
Q4 | $144K | Sell |
31,100
-4,282
| -12% | -$19.8K | ﹤0.01% | 2564 |
|
|
2017
Q3 | $251K | Sell |
35,382
-35,085
| -50% | -$249K | ﹤0.01% | 2356 |
|
|
2017
Q2 | $509K | Hold |
70,467
| – | – | ﹤0.01% | 2064 |
|
|
2017
Q1 | $434K | Buy |
+70,467
| New | +$434K | ﹤0.01% | 1968 |
|
|
2016
Q2 | – | Sell |
-2,703
| Closed | -$13K | – | 4061 |
|
|
2016
Q1 | $13K | Sell |
2,703
-319
| -11% | -$1.53K | ﹤0.01% | 3284 |
|
|
2015
Q4 | $16K | Sell |
3,022
-9,736
| -76% | -$51.5K | ﹤0.01% | 3248 |
|
|
2015
Q3 | $45K | Buy |
12,758
+12,558
| +6,279% | +$44.3K | ﹤0.01% | 2741 |
|
|
2015
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 3552 |
|
|
2015
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3511 |
|
|
2014
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 3400 |
|
|
2014
Q3 | $3K | Sell |
200
-2,230
| -92% | -$33.5K | ﹤0.01% | 3423 |
|
|
2014
Q2 | $37K | Buy |
2,430
+2,230
| +1,115% | +$34K | ﹤0.01% | 2934 |
|
|
2014
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3347 |
|
|
2013
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 3244 |
|
|
2013
Q3 | $2K | Sell |
200
-50
| -20% | -$500 | ﹤0.01% | 3257 |
|
|
2013
Q2 | $2K | Buy |
+250
| New | +$2K | ﹤0.01% | 3153 |
|